Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

[Combination drug therapy in patients with BPH].

Kuzmenko AV, Kuzmenko VV, Gyaurgiev TA.

Urologiia. 2018 Mar;(1):101-105. Russian.

PMID:
29634142
2.

Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction.

Traish A, Haider KS, Doros G, Haider A.

Horm Mol Biol Clin Investig. 2017 Jun 21;30(3). pii: /j/hmbci.2017.30.issue-3/hmbci-2017-0015/hmbci-2017-0015.xml. doi: 10.1515/hmbci-2017-0015.

PMID:
28632494
3.

Bioequivalence Studies of a Reformulated Dutasteride and Tamsulosin Hydrochloride Combination Capsule and a Commercially Available Formulation.

Kurczewski R, Bowen C, Collins D, Zhu J, Serbest G, Manyak M.

Clin Pharmacol Drug Dev. 2017 Sep;6(5):508-516. doi: 10.1002/cpdd.334. Epub 2017 Jan 27.

PMID:
28127948
5.

Impact of Formulation on the Pharmacokinetics of Dutasteride: Results from Two Phase I Studies.

Fossler M, Zhu J, Roehrborn C, McAleese P, Manyak M.

Clin Drug Investig. 2016 Sep;36(9):763-767. doi: 10.1007/s40261-016-0419-6.

PMID:
27356530
6.

Effect of tamsulosin on the pharmacokinetics of dutasteride in Chinese male healthy volunteers.

Li H, Yang J, Zhao H, Fossler MJ, Wang C.

Clin Pharmacol Drug Dev. 2015 Nov;4(6):427-33. doi: 10.1002/cpdd.197. Epub 2015 Jul 20.

PMID:
27137714

Supplemental Content

Loading ...
Support Center